Topical Retinaldehyde Increases Skin Content of Retinoic Acid and Exerts Biologic Activity in Mouse Skin  by Didierjean, Liliane et al.
Topical Retinaldehyde Increases Skin Content of 
Retinoic Acid and Exerts Biologic Activity in 
Mouse Skin 
Liliane Didierjean, Pierre Carraux, Denise Grand, Jorn Oliver Sass ,"'"!" Heinz Nau, '" and Jean-Hilaire Saurat 
Department of Dermatology, University H ospita l, Geneva, Switzerland ; and ' Insti tute fo r Toxicology and Embryo Pharmacology, Free 
University of Berlin, GenllallY 
Retinaldehyde, a natural lYletabolite of /3-carotene 
and retinol, has been proposed recently for topical 
use in hUlYlans. Because retinaldehyde does not bind 
to retinoid nuclear receptors, its biologic activity 
should result frOIYl enzYlYlatic transforInation by epi-
derlYlal keratinocytes into ligands for these receptors, 
such as all-trails retinoic acid and 9-cis-retinoic acid. 
In this study, we analyzed by high perforlYlance liquid 
chrolYlatography the type and alYlounts of tissue reti-
noids as well as several biologic activities resulting 
frOIYl topical application of either retinaldehyde or 
all- trans retinoic acid on lYlouse tail skin. Biologic 
activities of all-trans retinoic acid and retinaldehyde 
were qualitatively identical in lYletaplastic paralYle-
ters (induction of orthokeratosis, reduction of keratin 
65-kDa IYlRNA, increase in filaggrin and loricrin 
mRNAs) and hyperplastic paralYleters (increase in 
epiderInal thickness, increase in brolYlodeoxyuridine 
(BrdU)-positive cells, increase in keratin 50-kDa 
IYlRNA, and reduction in keratin 70-kDa InRNA). 
SOlYle quantitative differences, not all in favor of 
all-trailS retinoic acid, were found in several indices. 
E ndogenous retin oids in humans are derived from the intake of retinol (ROL) and its esters from food of animal origin and from carotenoids from plants (Un-derwood , 1994). Beta-carotene cl eavage enzym e cata-lyzes the conversion of aU-lfIlIIs-!3-carotene to two 
molecules of retinaldehyde (RAL), while several other carotenoids 
and apocarotenoids are also cleaved to yield RAL (Lakshman c/ ai, 
1989; van Vliet ct ai, 1991.) . RAL is also formed from ROL (Napoli 
and R ace, 1990). RAL is converted enzymatica lly into ROL, 
reti.nyl esters, or all - tflllls retinoic acid (at-RA) by human keratino-
cytes. T he process is dependen t on the diffe rentia tion stage of 
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Cellular retinoic acid-binding protein II and cellular 
retinol-binding protein I IYlRNAs were increased b y 
both topical retinaldehyde and all-tra.lls retinoic acid. 
Whereas all-tralls retinoic acid, 9-cis-retinoic acid, 
and 13-cis-retinoic acid were not detectable (liInit 5 
ng/g) in vehicle-treated skin, 0.05% retinaldehyde-
treated skin contained 13 ± 6.9 ng/g wet tissue o f 
all-trans retinoic acid (lYlean ± SD), 12.6 ± 5.9 ng/g 
13-cis-retinoic acid, and no 9-cis-retinoic acid. In 
contrast, 9-cis-retinoic acid was detectable in 0.05% o f 
all-tl'ans retinoic acid-treated skin, which also con-
tained 25-fold lYlore all-trailS retinoic acid and 5-fold 
more 13-cis-retinoic acid than retinaldehyde-treated 
skin. Our results show that topical retinaldehyde is 
transforlYled in vivo into all-tl'a1lS retinoic acid b y 
lTIOUSe epiderlYlis. The SlYlall alYlounts of ligand for 
retinoic acid nuclear receptors thus produced are 
sufficient to induce biologic effects silYlilar to those 
resulting frOIYl the topical application of the ligand 
itself in lYluch higher concentration. Key lVords: I'eti,,· 
oids/HPLC. ] Invest Derll/atoi 107:714-719, 1996 
keratinocytes, as it is higher in differentiating than i.n nondi!fcren-
tiated keratinocytes (Siegenthaler c/ ai, 1990) . I 
W e have therefore proposed that RAL may be used as a topical 
agent in humans to target multipotential vitamin A activity into 
distinct compartments of the epidermis. lndeed , topically applied 
RAL would (i) be handled only by the epidemlal cells having 
enzymatic activities at pertinent stages of difie rentiation; (ii) be a 
precursor ofROL, retinyl ester , or at-RA; and (iii) bypass the first, 
rate-limiting step of ROL oxidation into at-l~ . T his would result 
in controlled deli very of vitamin A metabolites to cells. We have 
found that RAL is well tolerated by human skin and that its topical 
application results in measurable biologic activity in the epidenllis 
(Saurat ct ai, 1994). 
Because l~L does not bind to retinoid nuclear receptors (Cret-
taz et ai, 1990), its biologic activity upon topical use should result 
from enzymatic tran sformation by epidermal keratinocytes into 
ligands for these receptors, such as at-l~ and 9-cis-l~ (Allenby el 
I C hattel ard-Gruaz D, jaconi S. Saurat jH. Siegenthaler G: Mecabolism of 
retinaIdehydc in living cultured human kcratinocytes. J bllles' Denllalol 
102:599 , 1994 (abstr.). 
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ai, 1993). The production of ligands for nuclear receptors within 
target cells has been defined as an "intracrine" process (O'Malley, 
1989). 
The aim of this study was first to analyze by high performance 
liquid chromatography (HPLC) the type and amounts of retinoids 
resulting from topica l application ofRAL in mouse skin to identify 
whe ther ligands for retinoid nuclear receptors are generated. The 
type and amounts of retinoids detectable after direct topical appli-
cation of a/-l~, the ligand for re tinoic acid receptors, were also 
analyzed for comparison . Second, we characterized the type and 
intensity of retinoid-induced biologic effects that may result from 
the generation of these ligands upon topical application of 1~L. 
T he mouse tail skin model was chosen because it allows one to 
analyze at the morphologic and molecular levels many biologic 
acriyjties of topical n/-RA (Schweizer and Marks, 1977; Didierjean 
et ai, 1983, Wrench and Didi eljean, 1985; Schweizer el ai , 1987). 
Topical nl-RA was used as a contro\. 
MATElUALS AND METHODS 
Chcnticals R.efercnce retinoids were mostly provided by Hoffmann-
LaRoch e (Basel, Switzerland). Retinyl esters (Collins et aI, 1992a) and 
aU-trnl1s-retinoyl-f3-D-glucuronide (Foerster ct ai, 1996) were synthesized 
in the Berlin laboratory by C h. Eckhoff and R. Reihl, respectivel y. The 
14-hy dro>.:y-retro-retin ol HPLC standard was a gift of Dr. J. Buck (Memorial 
Sloan-Kettering Cancer Center, New York, NY) . 
TrcatDlent of Mice AI-RA and RAL were used at concentrations of 
0.005, 0.01, 0.025, and 0.05% compounded in a same oil-in-water cream 
(Saurat of ai, 1994) . Cream samples of 0.5 g were applied daily for 9, 12. o r 
14 d on the tail. T he daily amount of RAL and at-RA delivered thus 
corresponded to 25, 50, 125 , or 250 /Lg. Groups of three or six adult (> 3 mo 
old) C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) were tested 
per dose/time point. Twenty hours after the last application, the anima ls 
were killed by decapitation . Tail skin was stripped o ff the bone and cut 
longitudinally, and one part, always fro m the same tai l region , was fLxed in 
Duboscq-Brasil liquid. embedded in paraffin, and processed for histology 
and morphometry. The remaining specimens were frozen in liquid nitrogen 
and kept at - 80°C. For retinoid analyses, tail skin received 14 d of vehicle, 
0.050/0 QI-RA, or RAL, and the entire tail skin was frozen in liquid nitrogen 
an.d kept at -80°C until extraction. 
Histology and Morphometry Five-micrometer serial sections were 
stained with helTI3toxytin and eosin. Measurcnlcnts were done using a 
micrometer at a lO X power field. The metaplastic response was studied by 
I measuring the length (/Lm) of parakeratotic epidermis in 100 interfollicular 
zones, i.e ., from the last granu lar cell of one zone to the first cell of the next 
fo llicular zone. Thickness of the epidermis (/Lm) was m easured at the 
middle of 1 00 intcrfollicular zones fro m the basal membrane zone to the last 
nuclea ted cell layer. All treatment IICI'SIIS vehicle values were assessed with 
tbe nonparametric Wilcoxon test. 
Measurement of Cell Proliferation W e measured the incorporation of 
DrdU into DNA. Mice were inj ected ineraperitoneally with 250 /Lg BrdU 
per g (Sigma Chemic, Buchs, Switzerland) dissolved in sterile physiologic 
saline. Mter 2 h, the animals were killed, and one part of the tail skin was 
fixed in Duboscq-Brasilliquid. embedded in paraffi n , and cut in 5- /Lm serial 
section s. Sections were dewaxed , placed in 0.05 M Tris(hydroxymethyl)-
aminomethane (Tris) buffer, pH 7.4, and then incubated in 1 N HCI at room 
temperature for 15 min and rinsed in Tris buffer. Slides were incubated with 
anci-BrdU monoclonal antibody (Boehringer Mannheim AG, Rotkreuz, 
Swi tzerland) di luted 1 :10 in Tris bufler for 1 h at room temperature. 
followed by staining by the Strept avid in-biotin peroxidase complex 
(ABC)/horseradish peroxidase (HIU» metllOd according to tile manufac-
turer's instructions (Dako Diagnostics Ag, Zug, Switzerland). Diaminoben-
,lidine (Sigma C hemie) was used as HRP substrate. Slides were observed by 
light microscopy at a magnifi cation of250 X . The number ofBrdU-positive 
cells in e pidermis of all interfollicular zoncs was counted and then expressed 
as cells per 100 interfollicular zones. 
RNA Isolation and Analysis Total ItNA was isolated using tile CsCI 
centrifugation method (Chirgwin el ai, 1979) and subjected to northern 
analysis or slot blotting. Hybridizations were performed either with ribo-
probes as described previously (Siegcnthaler et al. 1992) or with cDNAs 
labeled with [a -32Pjdeo,:ycytidine triphosphate to a specifIC activity of at 
least 1 X 108 cpm/ /Lg by random priming. Autoradiograms were analyzed 
by scaroling using a Phosphorlmagcr (Molecular Dynamics, Kemsing, UK). 
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Figure L Metaplastic responses to topical RAL and at-RA arc 
similar in mouse tail _ (AJ Time course, 0.05% at-l~ and 0.05% R AL. (B) 
Dose response at 14 d. Va lues arc expressed as the length (mean :!: SEM) of 
intcrfollicular orthokeratosis induced in 100 interfollicular zones measured 
in each of three animals per time/ dose. (C) Hemato ,.-ylin and eosin stain of 
skin showing the mctaplastic responsc (presence of a granular laycr) in til e 
interfollicular zone of mouse tail skin trea ted with 0.05% at-I'lA (2) or 
0.05% RAL (3) for 14 d, as compared with vehicle-treated tail (.1). 
Hybridization Probes FuJI-length murine cellular retinoic acid- binding 
protein type 11 and cellular re tinol-binding protein type I cDNAs were 
kindly provided by P. C ham bon (IGBM C, Illkirch. France). A specific 
cDNA fragment encoding for mouse loricrin (Mehrel et al. 1990) and cDNA 
fragment encoding for mouse fi laggrin (Rothnagcl et ai, 1987) were kindly 
provided by D . R. Roop (Baylor College of Medicine , Houston, TX); 
cDNAs encoding for murine 50-kDa (Knapp et al. 1987), 65-kDa, and 
70-kDa ker"tin proteins (Schweizer et ai, 1987) were kindly provided by J . 
Schweizer (German Cancer R esear ch Center. H eidelberg, Gemlany). 
Retinoid Analyses Retinoids were determined by reversed-phase HPLC 
with simultaneous detection at 340 and 356 nm using a modification 
(Tzimas ct aI , 1994; Sass ot ai, 1995) of the method described by Eckhoff and 
N au (1990). The modification allows the determination of didehydro-ROL, 
ROL, RAL, and retinyl esters in addition to polar retinoids. Before analysis , 
weighed tail skin samples were homogenized in a 4-fold volume of aqueous 
buffer (50 mM Tris-HCI, 25 mM NaCI, 2.5 mM ethylenediamine tetra acetic 
acid, 1 111M dithiothrcitol; pH 7.5). Under permanent cooling with ice, the 
skin was minced ,,<ith a pair of scissors and an Ultra-Turrax T 25 Oanke and 
Kunkel, Staufen, Germany) . Two hundred microliters of the homogenate 
were then mixed with 600 /LI of isopropanol, submitted to short somcation 
(So nitier B-12; Branson Sonic Power Company, Danbury, CT) at setting 
2.5, and centrifuged briefl y (6500 X g). Four hundred microliters of the 
resulting supernatant were extracted on a solid-phase cartridge as described 
by Collins et al (1992b). HPLC analyses were started witll a Varian AASP 
autoinjector, which inserted the cartridges into the stream of the HPLC 
elucnts. The limit of quantitation for each retinoid was 5 ng/g w e t weight 
of skin. For proper determination of aU-trallS-retinoyl-f3-D-glucuronide in 
skin samples, we used a binary gradient of different HPLC eluents (Sass and 
Nau, 1994). 
RESULTS 
Activity of Topical RAL Is Similar to That of At-RA 
Metaplastic R espoltsc The regular, highly ordered, postnatal pattem 
of parakeratotic scales and orthokeratotic interscale regions is 
changed to orthokeratosis in adult mouse tail by nt-RA. This 
metaplastic effect, which corresponds to a re tum to the neonatal 
pattern , is a retinoid-specific pharmacologic process that does not 
occur upon topical applica tion of the tumor promoter 12-0-
tetradecanoylphorbol-13-acetate (Schweizer et aI, 1987). T opical 
at-RA induced, as expected , a time- and con centration-dependent 
reduction of the parakeratotic scale regions, which were entirely 
replaced by orthokeratotic epidermis by 0.05% at-RA afte r 14 d 
(Schweizer et aI, 1987) (Fig 1). A time-dependent response similar 
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Figure 2. Expression levels of 65-kDa Icera tin (A ,B) a nd loricrin (G,D) mRNA arc similar in at-RA- and RAL-treated mouse tail skin. Mice 
w ere treated fo r 7 d w ith 0.005 , 0.010, and 0.05°1t, retino ids o r w ith vehicl e. (A,C) T riplicate experimen ts of RNA slot blots ofl f.Lg of tota l RNA hybridized 
by random priming. (B,D) Quantificatio n of J~A blots of nt-RA-treated or RAL-treated samples exp ressed 'IS perccntage of vchicle-treated samples 
(mean :!: SO). Statistica l a""lys is: paired Wilcoxon tcst. 
to that of al-RA was present in animals treated with RAL at 0.05% 
(Fig lA), althou gh RAL was significa ntly mo re m etaplastic at 
0.005, 0.01, and 0.025% in the dose-response experim ents (Fig 
IB). 
The expression of the murine type II 65-kDa keratin is sup-
pressed by at-RA, parallel to the induction of orthokeratosis, but 
no t by 12-0-tetradecanoylphorbol-13-acetate (Schweizer el aI, 
1987); topical al-l~ indeed induced a concentration-dependen t 
reduction in 65-kDa keratin mRNA as compared with vehicle (F ig 
2A) . Topical RAL also induced a reduction in 65-kDa keratin 
ml"tN A, w hich was not different from that indu ced by al-RA except 
at the lowest conccntration (0.005%), at w hi ch al-l~ was signifi-
cantly more active (p = (j.Ol) (Fig 2B). 
T he indu ction of orthokeratosis in the mouse tail corresponds to 
that of a granular layer; this layer expresses proteins such as loricrin 
and fi laggrin . Lo ricrin is abscnt in the mo use tail parakeratotic scale 
(Hohl el aI, 1993), and fi laggrin ml"tNAs are stably expressed only 
when kerati.nocytes migrate into the granular layer (Roth.nagel c/ ai, 
1987). T he expression of the loricrin gene was, as expected , 
induced by at-l~ but not by vehicle (Fig 2C,D) ; RAL also induced 
lori crin ml'tNA, bu t to a lesser extent (p = 0.02) . Fil aggrin ml'tNA 
was studied b y northern blot to analyze the 17-kb specific band 
(Rothnagel el aI, 1987). T reatm ent with 0.05% of al-RA and RAL 
induced an idcntical incrcasc in fi laggrin mRNA expression (14-
fo ld as compared w ith vehicle) . Low doses (0 .005% and 0.010%) of 
RAL resulted in 14- and 25-fold fila ggrin mRNA indu ction, vers tls 
9- and 16-fold, respecti ve ly, w ith al-RA (not shown). 
Hyperplas/ic Respotlsc In tlus model, a l -l~ induced a hyperplastic 
respo nse similar to that induced by 12-0-tetradecanoylphorbol-13-
acetatc (Schweizer ct aI, 1.987); this includes an in crease in epider-
mal thickness, ind uction of the murin e hyperproLiferatio n-associ-
ated type I 50-I<.Da ke ratin (the murine o rtholog of the human 
keratin K17), and suppression of the murine type 11 70- kDa keratin 
(the murine o rtho log of the human keratin K2e) (Sch weizer cl aI, 
1.987) . We analyzed these parameters and also stu died BrdU 
in corporation . 
BrdU-positivc cclls were signi ficantly more numerous in al-RA-
and RAL-treated skin than in vehicle, and in RAL as compared 
with al-RA treated skin, at the highest concentrations (Fig 3A). 
Topical al-RA increased epidermal thi ckness as expected; a 
similar effect was seen in mice treated with RAL, which induced 
significantly more thi ckening thall al-RA only at 0.05% (Fig 3B,C) . 
Topical af-RA induced , as expected , an increase in 50-kDa 
keratin ml"tNA; the induction by topical RAL was sigluiicantly 
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F igure 3 . H y perplastic responses to topical RAL and at-RA are 
similar in mouse tail. (A) BrdU-positive ce ll s in 100 interfollicular zones 
after 9 d of trcatmcnt with 0.005 and O.OS'X, of nt-ItA or !tAL (fold 
induction over vehicle contro l, 1l1 C~n ± SO, n = 3). *Signific3nt lI('rsus 
ve h.icle; U RAL ,' erSllS nt- I~. (B) 0.05% time course: thickness of epidermis 
(f.Lm/l00 in tcrfo llicul ar zones. mcan :!: SO. n = 3 per group). (C) do e 
response at 14 d . 
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Figure 4. Expression levels of 50-kDa (A,B) and 70-kDa keratin (C,D) mRNA arc similar in at-RA- and RAL-treated mouse tail skin. Mice 
were treated for 7 d with 0.005, 0.010, and 0.05% retinoids or with vehicle. (A, C) Triplicate experiments of RNA slot blots of l J.Lg of total RNA hybridized 
by random priming. (B,D) Q uantification of KNA blots of at-l~-treatcd or I~L-treated samples expressed as percentage of vehicle- treated samples 
(mean::!: SD) . 
bigher than th at by nt-RA (Fig 4A,B) . Topica l nt-l~ induced, as 
expected, a reduction in 70- kDa kera tin mRNA; topical RAL 
induced a similar redu ction in 70-kDa keratin mRNA (Fig 4C,D). 
Cellular Retilloic Acid- Bindillg Proteill Type 11 nlld Celllliar R etillol-
Biltdil1g Proteill Type I T he expression of these two retinoid-
binding proteins has been shown to be indu ced by nt-RA (Hirschel 
Scholz ct ai, 1989; Elder et ai , 1993; Piletta et ai, 1994; Kang et ai , 
1995); they may be considered as primary responsive genes be-
cause, unlike the other parameters analyzed in the present study, 
their promoters possess retinoid response elements (Smith cl ai, 
1991, Durand el al, 1992). Cellular retinoic acid-binding protein 
type II mRNA was induced 4-fold by at-lli and 2.5- fo ld by I~L; 
cellular retinol-binding protein type I mRNA was induced 1.3-fold 
by both at-RA and RAL (14 d , 0.05% not shown). 
A Low Amount of At-RA Is Generated in Mouse Skin upon 
Topical RAL Application We studied the retinoid content of 
tail skin by HPLC analysis after 14 d of treatment at optimal dose 
(0 .05% ). Compared with vehicle- treated con trols, RAL- trea ted 
mouse skin contained detectable amounts of at-l i and of 13-cis-
RA, w hereas 9-cis-RA, 4-oxo-RA, and didehydro-I~ were not 
detectable (Table I, Fig 5) . ROL content increased lO-fold afte r 
lliL application, which indicates that tai l skin had predominantly 
transformed lliL in to ROL. 
To put in perspective the data obtained with topical lliL. we 
studied the retinoid content in Ilf-RA-treated skill . It contained 
314- fo ld more Ilt-l~ than RAL- rreated skin . Interestingly, 9-cis-RA 
was detectable at significant levels, but 13-cis-RA was the main isomer 
form ed (Table I). No didehydro-l~ was detectable in af-RA-rreated 
skin , and 4-oxo-llis were only very minor metabolites, if present at 
all . A.ll-trlllls-re tinoyl-J3-D-glucul'Onide was fowld only after applica-
tion of Ilt-I~ (131 ± 11 ng/g wet weight) . 
Unlike in RAL-treated skin, in which af-RA should be form ed 
enzym atically fro m lliL, a signifi cant proportion of products 
detected in Ilt-RA-treated skin may sti ll be at the surface of tlle 
epidermis. We therefore conducted a second series of experiments 
in which the Ili-l~-trea ted tail was washed before sampling. 
Although Ilt-RA and isom ers were significantly decreased as com -
pared with unwashed tail (at-l~ by 92%, 13-cis-RA by 85°;(" and 
9-cis-l~ by 82%; Table I) , these were stin much higher than in 
RAL- trea ted unwashed skin ; tllUS there was still 24-fold m ore 
Ilt-RA (p = 0.05). 
ROL increased 2.5- fo ld in Ili-RA-trea ted skin but significantly 
less than in lliL-treated ski n (p = 0.001, Table I) . Because, unlike 
Table I. Retinoids in Mouse Tail Skin After 14 d of Topical Retinoid (0.05%) Application" 
Trcatn1en t 
Vehicle 
RAL 
A Il-fl'nlls- RA 
Unwashed skin 
Washed skin' 
All-t l'nllS- l~ 
NQ 
13.0 ± 6.9 
4080 ± 432 
310 ::!: 150 
" Sampling Wit S done 20 It after the last treatment. 
R etinoid Concentration in Tail Skin (ng/ g ww)" 
13-cis-l~ 9-cis-RA RAL 
N Q NQ NQ 
12.6 ± 5.9 NQ 350 ::!: 99.5 
409 ± 13 136 ::!: 13 NQ 
61.5 ::!: 27.2 24 .4 ± 10.2 NQ 
ROL 
69.8 ::!: 21.0 
749 ::!: 82 .7 
161 ± 2 
107 ± 18.7 
b Concentrations of 4-oxo- and didchydro-rctillQids were below th e limit of quantit;ltion (NQ) of the H PLC nll!thod «5 ng/ g wet weight) in nil samples excepr 4-oxo-ltAs 
in all-tra lls-RA unwashed skin (23 ± 2 ng/g wet weight). 
C The tail skin was washed with 0.1 % Triton. then rinsed with water before samplin g. 
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Figure 5_ A low amount of at-RA is generated in mouse skin upon 
topical RAL applicatioll_ Sample HPLC chromatograms of mouse tail 
skin obtained after 14 d of daily treatment (0 .05%) with L~ (A) (illsel1, 
magrlified RA peaks) and at-RA (B). Detection at 340 11m; 0.0320 AUFS, 
illsel1, 0.0009 AUFS. 
RAL, a/-RA cannot be transformed into ROL, it is likely that 
loading of the skin with a/-RA stimulates mobilization of ROL 
from endogenous retinyl esters, as has been shown in HeLa cells 
(Stenstrom el ai , 1996). This is further supported by the limited 
decrease in ROL detected in w'ashed versus unwashed tail skin 
(Table I) . 
DISCUSSION 
Previous observations in humans have indicated that topjcal RAL 
exerts some biologic activities (Saurat e/ ai, 1994). Our study 
confirms and extends these observations in the mouse tail. This is a 
reproducible model (Schweizer and Marks, 1977; Wrench and 
Didierjean, 1985) for studying the effects of topical at-RA at the 
morphologic and molecular levels (Schweizer el ai, 1987). The data 
obtained in this study in at-RA-treated mouse are well in accor-
dance with Schweizer's results (Schweizer and Marks, 1977; 
Schweizer el ai, 1987); therefore, because topical RAL also showed 
significant effects on all the parameters studied, it can be concluded 
that it exerts retinoid activities . 
Because RAL does not bind to retinoid nuclear receptors (Cret-
taz et ai, 1990), its retinoid biologic activity should result from its 
enzymatic transformation into n/-RA by epidermal keratinocytes. 
W e have indeed found that cytosolic extracts of cultured human 
keratinocytes transformed eH]RAL into CH]at-RA (Siegen thaler 
e/ ai, 1990) ; furthermore, intact cultured keratinocytes took up 
eH]RAL and transformed it into eH]al-RA. ' 
Our results now demonstrate that murine skin ill vivo also 
transforms RAL into at-RA. This indicates that RAL can be used 
topically as a precursor for at-RA, the ligand for retinoic acid 
receptors (Allenby et ai, 1993), which is likely to account for the 
retinoid biologic eHects observed. In tills context, it is interesting 
that, unlike topical at-RA, topical RAL did not generate detectable 
amounts of 9-cis-RA, the ligand for retinoid X receptors (Allenby 
et ai , 1.993). B ecause this was not correlated with major differences 
in the biologic effects of the two topical agents, it may be that RAL 
generated biologically sufficient amounts of 9-cis-RA that were 
below the detection limit of the assay (5 ng/g) . Mouse skin has also 
been shown to transform topical ROL into al-RA (Connor, 1988); 
a detailed comparison of the metabolites produced from topical 
ROL and RAL in tail skin is reported elsewhere (Sass el ai, in press) . 
ROL-treated skin showed no detectable RA, slightly less retillyl 
ester, but a signifi cant amount of 14-hydroxy-relro-ROL, a metab-
olite not previously reported in the skin. 
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Table II. Summary of the Biologic Activities of Topical 
RAL and AlI-tl'alls-RA Analyzed in This Study 
At-L~- Best Activity 
Activity spcci fi c(l by:b 
Induction of orthokcratosis Yes RAL 
Suppression of kcratin- 65 kDa Yes A t- RA 
Induction of loricrin NT A I-RA 
'Induction of fiJaggrin NT RAL 
Epidermal thickness No RAL 
BrdU incorporation N T RAL 
Kcratin 50-kDa induction No RAL 
Keratin 70-kDa suppression No Indcntical 
CRABP ll' NT A I-RA 
CRl3PI" NT Identical 
" Jndic .. tc~ (yes) thi.lt the activity has been shown wilh to p ical rctinoic acid but no t 
reproduced by topical 12-0-tetradccanoylpho rbol-13-acc tate (TPA) in the mouse tail 
model. according: to Schweizer ct nl (1987). NT indicates that the activi ty has not been 
tested w ith T PA in this model. 
/. Indicates higher activity in dose-response experiments (sec text). TillS should be 
considered to be Ihnited to this model and no t necessarily applicable to o thers. 
( C It.ABi>, cellular rctinoic add binding protein, 
II CIU3 P. cellu lar retinol binding prorcill . 
An important and surpnsmg observation was not only that 
topica l RAL showed both differentiating and proliferative activities 
qualitatively similar to those produced by at-l~ in tills model , but 
also that these activities were not quanti ta tively lower. Even if there 
were som e quantitative differences in the modulation of some of the 
parameters studied (summarized in Table II), these were not all in 
favor of a/-RA. This was surprising beca use we anticipated that 
when applied at 0.05%, RAL would be unable to provide as much 
a/-RA as that resulting from 0 .05% topically applied a/ -.RA. In fact, 
tlus prediction was clearly confirmed by our HPLC analysis, 
showing much lower tissue content of a/-RA after topical RAL than 
after topical at-RA. Such a discrepancy between tissue amounts of 
at-RA and biologi c activities may have at least two explanations, as 
follows . 
1.. A low concentration of topical al-RA (resulting in tissue levels 
in the range of 15 ng/g, i.e., the amount recovered after 0.05% 
RAL application) m ay be sufficient for full activity of the parame-
ters studied in tlus model. T illS is not likely w hen considering the 
dose-response curves of topica l at-RA; thus, 0.005% topical at-RA 
did not induce a full biologic effec t. 
2. The second possibility is more likely: After topical at-RA, only 
a small percentage of the al-I~ measured by HPLC analysis may 
correspond to intracelIular, biologically signifi cant a/-RA. There is 
no tool to test tlus hypothesis directly ill vir/D. It is, however, in 
agreement with the EDso of transcriptional activation by retinoic 
acid nuclear receptors, wlllch necessitates much lower amounts of 
at-RA than those recovered after topical application (Duell e/ ai, 
1992) . 
These data strongly support the concept of using precursors 
rather than a/-RA itself (Saurat ci ti l, 1994), because topical RAL 
loads epidermal celIs with low amounts of ligands that are a 
biologically significant as those resu lting from much Illgher tissue 
loading of al-l~. 
Together our data indicate that the intracrine concept (O'Malley, 
1989) is relevant to the field of topical retinoids . According to this 
concept, future studies should specifica IJ y address the applicability 
of the observations in the mouse to human skin . 
~Ve lizallk Ms. Clalldia PIIIIII for izer skillflll ICc/lllical ass isla lice. Tllis ",ork "'as 
sllpported ill part by tloe Delllsc/,e Forsc/lIIl1gsgelll eillsc/l~ft (5)1> 1 74, C6). 
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